Table 3.
Multivariate cox proportional hazard regression analysis of prognostic factors in patients with ESCC (n=252).
| HR (95%CI) | P | |
|---|---|---|
| OS | ||
| T stage | 0.002 | |
| T stage (T2 vs. T1) | 2.492 (0.290-21.405) | 0.405 |
| T stage (T3 vs. T1) | 3.341 (0.472-24.925) | 0.223 |
| T stage (T4 vs. T1) | 6.134 (0.844-44.550) | 0.073 |
| GTVnd (≥4.34 vs.<4.34cm3) | 1.949 (1.353-2.808) | < 0.001 |
| Gender (male vs. female) | 1.939 (1.013-3.712) | 0.046 |
| PFS | ||
| Gender (male vs. female) | 2.373 (1.242-4.535) | 0.009 |
| GTVnd (≥4.34 vs.<4.34cm3) | 1.425 (1.003-2.024) | 0.048 |
| Tumor location | 0.001 | |
| Tumor location (UT vs. Cervical) | 0.274 (0.146-0.514) | < 0.001 |
| Tumor location (MT vs. Cervical) | 0.543 (0.310-0.950) | 0.032 |
| Tumor location (LT vs. Cervical) | 0.475 (0.261-0.8) | 0.015 |
| DMFS | ||
| GTVnd (≥4.34 vs.<4.34cm3) | 2.548 (1.491-4.355) | 0.001 |
UT, Upper thoracic; MT, Middle thoracic; LT, Lower thoracic.